Emmaus Life Sciences Stock Forecast

Buy candidate since Jun 22, 2026 Gain 6.38%

The Emmaus Life Sciences, Inc. stock price gained 6.38% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.0113 to $0.0120. During the last trading day the stock fluctuated 11.11% from a day low at $0.0108 to a day high of $0.0120. The price has been going up and down for this period, and there has been a 16.62% gain for the last 2 weeks. Volume fell on the last day by -58 thousand shares and in total, 20 thousand shares were bought and sold for approximately $240.00 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.0131 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -14.48% during the next 3 months and, with a 90% probability hold a price between $0.0061 and $0.0112 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

EMMA Signals & Forecast

The Emmaus Life Sciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0105 and $0.0105. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, May 01, 2026, and so far it has risen 42.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Emmaus Life Sciences, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0101 and $0.0100. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Emmaus Life Sciences, Inc. finds support just below today's level at $0.0101. If this is broken, then the next support from accumulated volume will be at $0.0100 and $0.0096.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0012 between high and low, or 11.11%. For the last week the stock has had daily average volatility of 23.85%.

Our recommended stop-loss: $0.0116 (-3.38%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 35 days ago.)

Trading Expectations (EMMA) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Emmaus Life Sciences, Inc. to open at $0.0116, and during the day (based on 14 day Average True Range), to move between $0.0114 and $0.0126, which gives a possible trading interval of +/-$0.0013 (+/-11.40%) up or down from last closing price. If Emmaus Life Sciences, Inc. takes out the full calculated possible swing range there will be an estimated 11.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0130 (8.33%) than the support at $0.0101 (15.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Emmaus Life Sciences, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.569 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.0116 ( 3.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk